Lake Street upgraded Sight Sciences (SGHT) to Buy from Hold with a price target of $5, up from $3, following the company’s Q2 report. Stabilizing Surgical Glaucoma, “prudent” guidance, gross margins that were “not as bad as feared,” dry eye upside, and a “cheap valuation” are also cited by the analyst as reasons for the upgrade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT: